Dr. Foster Donald Lasley, MD

Dr. Lasley practices at Highlands Oncology Group PA in Springdale, Arkansas.

Dr. Lasley's NPI, 1407083058, was assigned on June 22, 2009. Dr. Lasley graduated from OU College of Medicine in 2009. Dr. Lasley holds Arkansas license E11178.

Dr. Lasley's primary practice is Highlands Oncology Group PA, at 3901 Parkway Cir, Springdale, AR 72762 in Washington County. The practice phone is (479) 587-1700.

Dr. Lasley's primary practice is Highlands Oncology Group PA in Springdale, Arkansas. Dr. Lasley is also affiliated with Mercy Hospital Northwest Arkansas. The medical group on file is Highlands Oncology Group. Dmand AI also links Dr. Lasley to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lasley practices, 3 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Lasley's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Lasley is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Lasley's licenses on file in 5 states: Arkansas, Indiana, Florida, Oklahoma and Texas.

Dmand AI lists anal cancer radiation, brain cancer radiation, breast cancer radiation, cancer radiation-upper GI, cervical cancer radiation, lung cancer radiation and prostate cancer radiation among the conditions Dr. Lasley treats.

CMS data shows 6,648 Medicare services from Dr. Lasley across 26 procedure codes in 2024, for 472 Medicare patients. Medicare paid $1,164,275 for them. Every service was in an office.

CMS counts 472 Medicare patients who saw Dr. Lasley in 2024. The largest group is 65 to 74, with 234 patients. 75% of them have cancer, and 75% have high blood pressure. 9% are also on Medicaid. Their average risk score is 1.93, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lasley's median patient age at 70, with 46% women.

In 2024, Dr. Lasley wrote 278 Medicare Part D claims for 107 patients. 96% of them were for generic drugs. CMS names the drug for 182 of them, across 9 drugs with 11 or more claims each, at $2,823 in total drug cost. In 2023, CMS named 33 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Lasley for performance year 2024, reported as part of a group. Dr. Lasley accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 4 papers to Dr. Lasley, published from 2015 to 2021. The most frequent topics are Carcinoma, Hepatocellular, Liver Neoplasms and Dose Fractionation, Radiation. Dr. Lasley has published most often in Pract Radiat Oncol. Dr. Lasley's most frequent co-authors are Higinia R. Cardenes, MD, Smith Apisarnthanarax, MD and Brian G. Czito, MD.

CMS Open Payments shows 495 general payments to Dr. Lasley from 66 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Novartis Pharmaceuticals Corporation paid the most, $866.

Dr. Lasley graduated from OU College of Medicine in 2009.

Dr. Lasley is in network with 20 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Cigna. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.